InvestSMART

Anteris Technologies Ltd (ASX: AVR) - Announcements

Current share price for AVR : $11.560 0.93 (7.45%)+

ASX company news and announcements for Anteris Technologies Ltd (AVR) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Anteris Technologies Ltd (AVR) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Anteris Technologies Ltd (AVR), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Anteris Technologies Ltd (AVR)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$176 Notification regarding unquoted securities - AVR 14 Apr 2026 2:43PM $8.480 $11.560 risen by 36.32%
$176 Application for quotation of securities - AVR 13 Apr 2026 12:37PM $7.850 $11.560 risen by 47.26%
$176 Statement of CDIs on issue - AVR 7 Apr 2026 3:26PM $7.550 $11.560 risen by 53.11%
$176 Notification of cessation of securities - AVR 1 Apr 2026 7:13PM $7.880 $11.560 risen by 46.70%
$176 Notification regarding unquoted securities - AVR 12 Mar 2026 12:56PM $9.100 $11.560 risen by 27.03%
$176 Statement of CDIs on issue - AVR 5 Mar 2026 11:09AM $8.900 $11.560 risen by 29.89%
$176 Notification of cessation of securities - AVR 4 Mar 2026 10:07AM $9.000 $11.560 risen by 28.44%
$176 Corporate Governance Statement and Appendix 4G 27 Feb 2026 9:46AM $8.870 $11.560 risen by 30.33%
$176 2025 Financial Results and Corporate Update 27 Feb 2026 9:31AM $8.870 $11.560 risen by 30.33%
$176 Annual Report to shareholders 27 Feb 2026 9:19AM $8.870 $11.560 risen by 30.33%
$176 Underwritten Offering - End of Stabilisation Period 25 Feb 2026 6:13PM $8.600 $11.560 risen by 34.42%
$176 Statement of CDIs on issue - AVR 5 Feb 2026 5:42PM $7.800 $11.560 risen by 48.21%
$176 Notification of cessation of securities - AVR 3 Feb 2026 6:43PM $8.610 $11.560 risen by 34.26%
$176 Cleansing Notice 23 Jan 2026 9:44AM $8.910 $11.560 risen by 29.74%
$176 Notification regarding unquoted securities - AVR 23 Jan 2026 9:41AM $8.910 $11.560 risen by 29.74%
$176 Strategic Investment from Medtronic-$US320M Aggregate Raises 23 Jan 2026 9:37AM $8.910 $11.560 risen by 29.74%
$176 Closing of $US 230M Public Offering 23 Jan 2026 9:29AM $8.910 $11.560 risen by 29.74%
$176 Entry into a Material Definitive Agreement 23 Jan 2026 9:25AM $8.910 $11.560 risen by 29.74%
$176 Prospectus Supplement 22 Jan 2026 2:55PM $8.840 $11.560 risen by 30.77%
$176 Proposed issue of securities - AVR 21 Jan 2026 3:17PM $7.290 $11.560 risen by 58.57%
$176 Pricing of Offering 21 Jan 2026 3:17PM $7.290 $11.560 risen by 58.57%
$176 Preliminary Prospectus Supplement 21 Jan 2026 8:57AM $7.290 $11.560 risen by 58.57%
$176 Trading Halt 21 Jan 2026 8:43AM $7.290 $11.560 risen by 58.57%
$176 Proposed $US200m Offering & Medtronic Strategic Investment 21 Jan 2026 8:37AM $7.290 $11.560 risen by 58.57%
$176 Statement of CDIs on issue - AVR 8 Jan 2026 3:16PM $7.340 $11.560 risen by 57.49%

26 - 50 of 695 results

Page 2 of 28

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.